Medpace Holdings (MEDP) EBITDA Margin (2015 - 2026)
Medpace Holdings (MEDP) reported EBITDA Margin of 20.98% for Q1 2026, down 54.0% on a YoY basis from 45.61% in Q1 2025, and down 7.21% quarter-over-quarter from 22.61% in Q4 2025.
Medpace Holdings (MEDP) EBITDA Margin (2015 - 2026) Analysis & Trends
Medpace Holdings has reported EBITDA Margin for 12 years, with the latest figure at 20.98% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 54.0% year-over-year to 20.98%; the trailing twelve-month figure through Mar 2026 stood at 22.04% (down 42.0% YoY), and the FY2025 full-year result was 22.22%, down 29.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 20.98%, down from 22.61% in the prior quarter.
- The five-year high for EBITDA Margin was 24.7% in Q4 2024, with the low at 18.31% in Q2 2023.
- Historically, EBITDA Margin has averaged 21.05% across 5 years, with a median of 21.21% in 2024.
- Annual changes were most pronounced in 2023 — EBITDA Margin tumbled 305 bps — and 2024, when it surged 589 bps.
- Medpace Holdings' EBITDA Margin stood at 20.68% in 2022, then retreated by 9 bps to 18.81% in 2023, then surged by 31 bps to 24.7% in 2024, then dropped by 8 bps to 22.61% in 2025, then fell by 7 bps to 20.98% in 2026.
- The last three EBITDA Margin figures came in at 20.98% (Q1 2026), 22.61% (Q4 2025), and 22.52% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 21.74% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.21% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 19.42% |
| 10 | Medpace Holdings | 13.31 Bn | 12.66 Bn | 196.33 Mn | 20.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.98% |
| Dec 31, 2025 | 22.61% |
| Sep 30, 2025 | 22.52% |
| Jun 30, 2025 | 22.06% |
| Mar 31, 2025 | 21.52% |
| Dec 31, 2024 | 24.70% |
| Sep 30, 2024 | 22.39% |
| Jun 30, 2024 | 21.21% |
| Mar 31, 2024 | 21.66% |
| Dec 31, 2023 | 18.81% |
| Sep 30, 2023 | 18.53% |
| Jun 30, 2023 | 18.31% |
| Mar 31, 2023 | 21.11% |
| Dec 31, 2022 | 20.68% |
| Sep 30, 2022 | 21.57% |
| Jun 30, 2022 | 18.49% |
| Mar 31, 2022 | 20.69% |
| Dec 31, 2021 | 19.13% |
| Sep 30, 2021 | 19.55% |
| Jun 30, 2021 | 16.67% |